Product Announcement from Takeda

red blood cells

The Hemophilia Federation of America is writing to share a product announcement from Takeda.

Download the Patient Letter from Takeda.

Please sign up for the Patient Notification System (PNS) to receive direct notifications about the latest recalls or withdrawals of recombinant and plasma products.

HFA will continue to update our community on changes to healthcare policy, access, and treatment, including potential issues and recalls of medication. Be sure to follow us and join HFA to stay up to date on upcoming developments in the future. 

en_USEnglish